As we look ahead to 2024, the cannabis industry continues to evolve, presenting exciting investment opportunities. The 5StarsStocks Cannabis landscape has caught our attention, with several companies standing out as potential leaders in this growing market. 5StarsStocks Cannabis believe that understanding the key players and trends in the cannabis sector is crucial for investors looking to capitalize on this dynamic industry.
In this 5StarsStocks.com article, we’ll explore the top multi-state operators (MSOs) to keep an eye on, as well as Canadian cannabis giants with plans to expand into the U.S. market. We’ll also discuss ancillary cannabis stocks that show promise for growth. Additionally, we’ll break down the main factors that we think will drive cannabis stock performance in 2024. By the end, you’ll have a clearer picture of the best marijuana stocks to buy and the potential risks and rewards of investing in this sector.
Top Multi-State Operators (MSOs) to Watch
As we explore the 5StarsStocks Cannabis landscape, we’ve identified several multi-state operators (MSOs) that stand out as potential leaders in the US cannabis stocks market. These companies have demonstrated strong performance and growth potential, making them some of the best marijuana stocks to buy for investors looking to invest in cannabis.
Green Thumb Industries (GTBIF)
Green Thumb Industries has caught our attention as a top player in the cannabis industry. We’ve observed that GTBIF has been making significant strides in expanding its retail footprint and enhancing its product offerings. The company operates 91 dispensaries across 15 U.S. states, giving it a strong presence in the market.
In the first quarter of 2024, Green Thumb Industries reported impressive financial results. We saw total revenue reach USD 275.80 million, marking an 11% increase from the previous year. What’s more, the company achieved a robust gross profit of USD 144.90 million, representing 52.5% of revenue. This is an improvement from 50.2% in the first quarter of 2023.
We’re particularly impressed by Green Thumb’s adjusted EBITDA for the first quarter, which stood at USD 90.50 million or 32.8% of revenue. This shows a notable increase from USD 76.20 million or 30.7% of revenue in Q1 of 2023. The company’s strong liquidity position, with USD 223.90 million in cash and cash equivalents, further strengthens its investment potential.
Trulieve Cannabis (TCNNF)
Trulieve Cannabis has also caught our eye as a leading MSO in the U.S. cannabis industry. We’ve noticed that TCNNF has been actively expanding its presence, particularly in Florida. The company recently opened new medical cannabis dispensaries in Madison and Panama City, Florida, showcasing its commitment to growth.
Trulieve’s financial performance in Q1 2024 was noteworthy. 5StarsStocks Cannabis observed that revenue reached USD 298.00 million, a 4% increase from the previous quarter. The company achieved a robust gross margin of 58%, translating to a gross profit of USD 174.00 million. Despite reporting a net loss of USD 23.00 million, this marked a significant improvement both sequentially and year-over-year.
We’re impressed by Trulieve’s strong cash flow, generating USD 139.00 million from operations and USD 124.00 million in free cash flow during the quarter. This has bolstered its financial position, with cash reserves totaling USD 327.00 million by quarter-end.
Curaleaf Holdings (CURLF)
Curaleaf Holdings rounds out our list of top MSOs to watch in the 5StarsStocks Cannabis market. We’ve noticed that CURLF has the largest geographical reach of any American cannabis company, operating in 17 states with 147 retail locations and over 900 wholesale partner accounts nationwide.
In 2023, Curaleaf reported full-year revenue of USD 1.37 billion, a 2.62% increase compared to 2022. The company’s Q4 2023 revenue stood at USD 345.30 million, a 4% increase from the previous quarter. We’re particularly impressed by Curaleaf’s adjusted gross profit margin for Q4 2023, which was 48%, up 120 basis points from Q3 2023.
Looking ahead, Curaleaf aims for mid-single-digit top-line growth and a mid-20% adjusted EBITDA margin for 2024. 5StarsStocks Cannabis believe these initiatives could bolster revenue growth and market share, making CURLF an interesting option for those looking to invest in cannabis stocks.
Canadian Cannabis Giants with U.S. Expansion Plans
As we look at the 5StarsStocks Cannabis landscape, we’ve noticed that Canadian cannabis companies are also making moves to capitalize on the potential U.S. market. These firms are positioning themselves to take advantage of expected regulatory advancements and expansion opportunities in the United States. Let’s explore two major players in this space.
Canopy Growth Corporation (CGC)
We’ve been keeping a close eye on Canopy Growth’s strategy, which centers around hopes for cannabis legalization in the U.S. The company has taken an innovative approach by creating Canopy USA, a special purpose vehicle designed to hold its positions in U.S.-based businesses. This structure allows Canopy to maintain its Nasdaq Stock Market listing while preparing for potential U.S. market entry.
Canopy USA has recently exercised its options to acquire both Wana and Jetty, two significant players in the U.S. cannabis market. This move marks a critical step in Canopy’s ambition to become a leading brand-focused powerhouse in the U.S. cannabis industry.
We’ve observed that Canopy Growth is focusing on maintaining brand autonomy within its portfolio. David Klein, CEO of Canopy Growth, emphasized that the intent is to keep the brands whole and allow the business to develop organically. This approach could help preserve the unique strengths of each brand while benefiting from the synergies of the larger organization.
Tilray Brands (TLRY)
Tilray Brands has caught our attention with its proactive approach to U.S. expansion. Unlike some competitors who are waiting for full legalization, Tilray has been making strategic moves to grow its presence in the U.S. market through alternative channels.
5StarsStocks Cannabis have noticed that Tilray has diversified its portfolio by acquiring alcohol beverage brands, becoming one of the top craft brewers in the U.S. market. This strategy has allowed Tilray to establish a foothold in the U.S. while navigating the current regulatory landscape.
Recently, Tilray announced plans to raise up to USD 250.00 million through an at-market offering. The company intends to use these funds for strategic and accretive acquisitions or investments, including potential acquisitions of assets in the U.S. This move signals Tilray’s readiness to capitalize on opportunities in the U.S. cannabis market as regulatory changes unfold.
5StarsStocks Cannabis believe that Tilray’s diversification strategy could give it an edge in the competitive cannabis market. By expanding into alcohol and other wellness products, Tilray has the potential to achieve wider margins and improve its profitability. This approach might put Tilray in a stronger position compared to companies solely focused on cannabis.
As we continue to monitor the 5StarsStocks Cannabis landscape, we’ll keep a close eye on how these Canadian giants navigate the evolving U.S. market. Their strategies for U.S. expansion could significantly impact their growth potential and make them interesting options for those looking to invest in cannabis stocks.
Ancillary Cannabis Stocks with Growth Potential
In our exploration of the 5StarsStocks Cannabis landscape, we’ve identified some promising ancillary cannabis stocks that show significant growth potential. These companies, while not directly involved in growing or selling cannabis, provide essential services and products to the industry. Let’s take a closer look at two standout players in this space.
GrowGeneration (GRWG)
GrowGeneration has caught our attention as one of the largest retailers and distributors of specialty hydroponic and organic gardening products in the United States. We’ve observed that GRWG has been making strategic moves to strengthen its position in the market.
In the second quarter of 2024, GrowGeneration reported some encouraging results. 5StarsStocks Cannabis saw net sales increase by 11.8% quarter-over-quarter to USD 53.50 million. What’s more, the company’s proprietary brand sales as a percentage of Cultivation and Gardening net sales rose to 21.5%, up from 16.7% in the same period last year.
We’re particularly impressed by GrowGeneration’s focus on improving profitability. The company achieved a gross profit margin of 26.9%, a 110 basis point sequential improvement. Additionally, operating expenses decreased by USD 2.50 million compared to the second quarter of 2023.
Looking ahead, GrowGeneration has announced a comprehensive restructuring plan aimed at driving long-term profitability and advancing growth initiatives. The company is targeting proprietary brands to account for 35% of total sales by the end of 2025. 5StarsStocks Cannabis believe this strategy, along with the launch of a B2B e-commerce portal and streamlining of operations, could position GRWG for future growth in the cannabis industry.
Innovative Industrial Properties (IIPR)
Innovative Industrial Properties has grabbed our attention as a unique player in the cannabis space. As a real estate investment trust (REIT) specializing in the regulated cannabis industry, IIPR provides real estate capital to state-licensed cannabis operators.
We’ve noticed that IIPR operates a sale-leaseback program, acquiring freestanding industrial and retail properties and leasing them back to state-licensed cannabis operators under long-term, absolute net lease agreements. This approach has allowed the company to build a portfolio of properties leased to well-capitalized companies that have successfully navigated the rigorous state licensing process.
What impresses us about IIPR is its consistent performance. The company has shown a remarkable 5-year average adjusted funds from operations (AFFO) growth of 47%, accompanied by a 39% increase in dividend payout during the same period. Currently, IIPR offers an attractive 7% yield while trading at just 11.34 times forward AFFO.
We’re encouraged by IIPR’s recent performance as well. In its Q4 results, the company surpassed FFO and revenue estimates, collecting 100% rent despite some tenant-related issues in the past year. Furthermore, IIPR is committing USD 119.50 million to acquire new properties, initiate new leases, and adjust existing leases, demonstrating its commitment to growth and adaptation in the evolving cannabis market.
As we continue to monitor the 5StarsStocks Cannabis landscape, we believe these ancillary stocks present interesting opportunities for investors looking to gain exposure to the cannabis industry without directly investing in plant-touching businesses.
Key Factors Driving Cannabis Stock Performance in 2024
As we analyze the 5StarsStocks Cannabis landscape, we’ve identified several key factors that are likely to have a significant impact on cannabis stock performance in 2024. These factors are shaping the industry and influencing investment decisions for those looking to invest in cannabis stocks.
Potential U.S. Federal Legalization
5StarsStocks Cannabis believe that the potential for U.S. federal legalization is one of the most crucial factors driving cannabis stock performance. The decisions made in 2024 may represent the biggest reform in federal cannabis policy in the past 40 years. This could have a profound impact on the best marijuana stocks to buy.
5StarsStocks Cannabis observed that five more states are planning to take cannabis legislation to the polls this year. Florida, Hawaii, New Hampshire, Pennsylvania, and South Dakota have a realistic chance to legalize adult-use marijuana. Additionally, medical cannabis legalization could advance in four states. This expansion of legal markets could boost the investment potential of cannabis stocks.
According to 5StarsStocks Cannabis projections, total revenue from cannabis is expected to reach USD 39.85 billion in 2024. This growth trajectory is encouraging for those looking to invest in cannabis. However, it’s important to note that the absence of federal legalization still poses significant challenges for cannabis entrepreneurs, particularly in terms of access to traditional funding sources.
International Market Expansion
5StarsStocks Cannabis have noticed that international market expansion is another key factor influencing cannabis stock performance. The global cannabis market is projected to reach over USD 67.00 billion in revenue by 2028 as the legalization movement surrounding cannabis evolves.
Canada, for instance, has seen positive performance in its adult-use segment, which has outweighed the structural decline in medical cannabis. In Germany, there are high expectations for the future of legal cannabis. Even in Japan, where negative perceptions towards cannabis strongly prevail, we’re seeing the development of an industry.
This international growth presents opportunities for cannabis stocks with global ambitions. Companies that can successfully navigate these emerging markets may see significant gains in their stock performance.
Mergers and Acquisitions
5StarsStocks Cannabis have observed that mergers and acquisitions (M&A) are playing a crucial role in shaping the cannabis industry and influencing stock performance. The contractions of the cannabis industry have created a realignment in the sector following its early explosive success.
Instead of blockbuster acquisitions and rapid multi-state expansion, we’re seeing that small and midsize businesses (SMBs) are now the focus of most M&A activity. Savvy businesses are looking for mutually beneficial partnerships that allow them to maintain a foothold in the market to ride out this correction.
For example, we’ve noticed that Planet 13 entered an agreement to acquire a Las Vegas dispensary for USD 6.90 million. Similarly, SNDL was selected as the successful bidder to acquire Indiva, a move expected to enhance SNDL’s product offerings and further solidify the company’s position in the Canadian cannabis market.
These M&A activities can significantly impact stock performance, as they often lead to increased market share, improved efficiencies, and enhanced product offerings. For investors in cannabis stocks, keeping an eye on these developments could be crucial in identifying investment opportunities and managing investment risks.
Conclusion on 5StarsStocks Cannabis
The 5StarsStocks Cannabis industry’s evolution presents exciting opportunities for investors in 2024. Multi-state operators like Green Thumb Industries, Trulieve Cannabis, and Curaleaf Holdings are showing strong growth potential in the U.S. market. Canadian giants such as Canopy Growth and Tilray are positioning themselves to enter the U.S. scene, while ancillary stocks like GrowGeneration and Innovative Industrial Properties offer unique ways to gain exposure to the sector.
Looking ahead, several factors will shape the performance of 5StarsStocks Cannabis stocks. The possibility of U.S. federal legalization has a significant influence on the industry’s future. Global market expansion opens up new avenues for growth, while mergers and acquisitions continue to reshape the competitive landscape. To make informed decisions, investors should keep a close eye on these trends and carefully weigh the risks and rewards of investing in this dynamic sector.
